Effect of docosahexaenoic acid on the generation of platelet-activating factor by eosinophilic leukemia cells, Eol-1

Mayumi Shikano, Yasuo Masuzawa, Kazunaga Yazawa

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Human eosinophilic leukemia (Eol-1) cells were examined for their ability to generate platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) (PAF) and the effect of supplementation of docosahexaenoic acid (C22:6n-3) on the PAF synthesis was explored in relation to the fatty acid composition of phospholipids and the liberation of arachidonic acid (C20:4n-6 AA). Alhough undifferentiated cells did not produce PAF, the exposure of IFN-γ differentiated Eol-1 to generate PAF in response to the Ca-ionophore. In addition, the IFN-γ-treated cells acquired the ability to release free fatty acids, approximately 55% of which was found to be AA. When DHA was supplemented into the culture of Eol-1 for 24 h, PAF production decreased by 40 to 50% at concentrations of 3 to 10 μM. On the other hand, supplementation of 10 μM eicosapentaenoic acid (C20:5n-3) did not significantly decrease PAF production. With the supplementation of 10 μM DHA, DHA levels in phospholipid subclasses, including alkylacylglycerophosphocholine, were greatly increased with concurrent decreases in other unsaturated-fatty acids. In these cells, the liberation of AA in response to an ionophore was decreased by 55%. Even when DHA was enriched in phospholipids, DHA release in response to ionophore stimulation was almost negligible, indicating that the DHA moiety of phospholipids is not susceptible to the action of phospholipase A2. Furthermore, DHA supplementation appeared to attenuate phospholipase A2 reaction by some unknown mechanism because the decrease in AA release was much more than that for the AA level in phospholipids. Acetyl-CoA:1-alkylGPC acetyltransferase activity of stimulated cell lysate was also reduced by DHA supplementation but the reduction was much less when compared with that of PAF synthesis or AA release. These results implicated that enrichment of DHA attenuates enzymic reactions for PAF synthesis, mainly the initial reaction catalyzed by AA-specific phos-pholipase, and thereby reduces PAF synthesis in Eol-1.

Original languageEnglish
Pages (from-to)3525-3533
Number of pages9
JournalJournal of Immunology
Volume150
Issue number8 PART 1
Publication statusPublished - 1993
Externally publishedYes

Fingerprint

Hypereosinophilic Syndrome
Docosahexaenoic Acids
Platelet Activating Factor
Phospholipids
Ionophores
Phospholipases A2
Acetyl Coenzyme A
Acetyltransferases
Eicosapentaenoic Acid
Phosphorylcholine
Unsaturated Fatty Acids
Nonesterified Fatty Acids
Arachidonic Acid
Fatty Acids

ASJC Scopus subject areas

  • Immunology

Cite this

Effect of docosahexaenoic acid on the generation of platelet-activating factor by eosinophilic leukemia cells, Eol-1. / Shikano, Mayumi; Masuzawa, Yasuo; Yazawa, Kazunaga.

In: Journal of Immunology, Vol. 150, No. 8 PART 1, 1993, p. 3525-3533.

Research output: Contribution to journalArticle

Shikano, Mayumi ; Masuzawa, Yasuo ; Yazawa, Kazunaga. / Effect of docosahexaenoic acid on the generation of platelet-activating factor by eosinophilic leukemia cells, Eol-1. In: Journal of Immunology. 1993 ; Vol. 150, No. 8 PART 1. pp. 3525-3533.
@article{5319abbb43a24ecd9e98dc67b117454c,
title = "Effect of docosahexaenoic acid on the generation of platelet-activating factor by eosinophilic leukemia cells, Eol-1",
abstract = "Human eosinophilic leukemia (Eol-1) cells were examined for their ability to generate platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) (PAF) and the effect of supplementation of docosahexaenoic acid (C22:6n-3) on the PAF synthesis was explored in relation to the fatty acid composition of phospholipids and the liberation of arachidonic acid (C20:4n-6 AA). Alhough undifferentiated cells did not produce PAF, the exposure of IFN-γ differentiated Eol-1 to generate PAF in response to the Ca-ionophore. In addition, the IFN-γ-treated cells acquired the ability to release free fatty acids, approximately 55{\%} of which was found to be AA. When DHA was supplemented into the culture of Eol-1 for 24 h, PAF production decreased by 40 to 50{\%} at concentrations of 3 to 10 μM. On the other hand, supplementation of 10 μM eicosapentaenoic acid (C20:5n-3) did not significantly decrease PAF production. With the supplementation of 10 μM DHA, DHA levels in phospholipid subclasses, including alkylacylglycerophosphocholine, were greatly increased with concurrent decreases in other unsaturated-fatty acids. In these cells, the liberation of AA in response to an ionophore was decreased by 55{\%}. Even when DHA was enriched in phospholipids, DHA release in response to ionophore stimulation was almost negligible, indicating that the DHA moiety of phospholipids is not susceptible to the action of phospholipase A2. Furthermore, DHA supplementation appeared to attenuate phospholipase A2 reaction by some unknown mechanism because the decrease in AA release was much more than that for the AA level in phospholipids. Acetyl-CoA:1-alkylGPC acetyltransferase activity of stimulated cell lysate was also reduced by DHA supplementation but the reduction was much less when compared with that of PAF synthesis or AA release. These results implicated that enrichment of DHA attenuates enzymic reactions for PAF synthesis, mainly the initial reaction catalyzed by AA-specific phos-pholipase, and thereby reduces PAF synthesis in Eol-1.",
author = "Mayumi Shikano and Yasuo Masuzawa and Kazunaga Yazawa",
year = "1993",
language = "English",
volume = "150",
pages = "3525--3533",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "8 PART 1",

}

TY - JOUR

T1 - Effect of docosahexaenoic acid on the generation of platelet-activating factor by eosinophilic leukemia cells, Eol-1

AU - Shikano, Mayumi

AU - Masuzawa, Yasuo

AU - Yazawa, Kazunaga

PY - 1993

Y1 - 1993

N2 - Human eosinophilic leukemia (Eol-1) cells were examined for their ability to generate platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) (PAF) and the effect of supplementation of docosahexaenoic acid (C22:6n-3) on the PAF synthesis was explored in relation to the fatty acid composition of phospholipids and the liberation of arachidonic acid (C20:4n-6 AA). Alhough undifferentiated cells did not produce PAF, the exposure of IFN-γ differentiated Eol-1 to generate PAF in response to the Ca-ionophore. In addition, the IFN-γ-treated cells acquired the ability to release free fatty acids, approximately 55% of which was found to be AA. When DHA was supplemented into the culture of Eol-1 for 24 h, PAF production decreased by 40 to 50% at concentrations of 3 to 10 μM. On the other hand, supplementation of 10 μM eicosapentaenoic acid (C20:5n-3) did not significantly decrease PAF production. With the supplementation of 10 μM DHA, DHA levels in phospholipid subclasses, including alkylacylglycerophosphocholine, were greatly increased with concurrent decreases in other unsaturated-fatty acids. In these cells, the liberation of AA in response to an ionophore was decreased by 55%. Even when DHA was enriched in phospholipids, DHA release in response to ionophore stimulation was almost negligible, indicating that the DHA moiety of phospholipids is not susceptible to the action of phospholipase A2. Furthermore, DHA supplementation appeared to attenuate phospholipase A2 reaction by some unknown mechanism because the decrease in AA release was much more than that for the AA level in phospholipids. Acetyl-CoA:1-alkylGPC acetyltransferase activity of stimulated cell lysate was also reduced by DHA supplementation but the reduction was much less when compared with that of PAF synthesis or AA release. These results implicated that enrichment of DHA attenuates enzymic reactions for PAF synthesis, mainly the initial reaction catalyzed by AA-specific phos-pholipase, and thereby reduces PAF synthesis in Eol-1.

AB - Human eosinophilic leukemia (Eol-1) cells were examined for their ability to generate platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) (PAF) and the effect of supplementation of docosahexaenoic acid (C22:6n-3) on the PAF synthesis was explored in relation to the fatty acid composition of phospholipids and the liberation of arachidonic acid (C20:4n-6 AA). Alhough undifferentiated cells did not produce PAF, the exposure of IFN-γ differentiated Eol-1 to generate PAF in response to the Ca-ionophore. In addition, the IFN-γ-treated cells acquired the ability to release free fatty acids, approximately 55% of which was found to be AA. When DHA was supplemented into the culture of Eol-1 for 24 h, PAF production decreased by 40 to 50% at concentrations of 3 to 10 μM. On the other hand, supplementation of 10 μM eicosapentaenoic acid (C20:5n-3) did not significantly decrease PAF production. With the supplementation of 10 μM DHA, DHA levels in phospholipid subclasses, including alkylacylglycerophosphocholine, were greatly increased with concurrent decreases in other unsaturated-fatty acids. In these cells, the liberation of AA in response to an ionophore was decreased by 55%. Even when DHA was enriched in phospholipids, DHA release in response to ionophore stimulation was almost negligible, indicating that the DHA moiety of phospholipids is not susceptible to the action of phospholipase A2. Furthermore, DHA supplementation appeared to attenuate phospholipase A2 reaction by some unknown mechanism because the decrease in AA release was much more than that for the AA level in phospholipids. Acetyl-CoA:1-alkylGPC acetyltransferase activity of stimulated cell lysate was also reduced by DHA supplementation but the reduction was much less when compared with that of PAF synthesis or AA release. These results implicated that enrichment of DHA attenuates enzymic reactions for PAF synthesis, mainly the initial reaction catalyzed by AA-specific phos-pholipase, and thereby reduces PAF synthesis in Eol-1.

UR - http://www.scopus.com/inward/record.url?scp=0027159589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027159589&partnerID=8YFLogxK

M3 - Article

C2 - 8468486

AN - SCOPUS:0027159589

VL - 150

SP - 3525

EP - 3533

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 8 PART 1

ER -